InvestSMART

Alterity Therapeutics Limited (ASX: ATH) - Announcements

Current share price for ATH : $0.525 0.03 (5.41%)+

ASX company news and announcements for Alterity Therapeutics Limited (ATH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alterity Therapeutics Limited (ATH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alterity Therapeutics Limited (ATH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alterity Therapeutics Limited (ATH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$114 Application for quotation of securities - ATH 18 Jan 2024 10:36AM $0.005 $0.525 risen by 10,400%
$114 Change in substantial holding 18 Jan 2024 8:18AM $0.005 $0.525 risen by 10,400%
$114 Change in substantial holding 12 Jan 2024 8:19AM $0.004 $0.525 risen by 13,025%
$114 Change of Director's Interest Notice PM BM 11 Jan 2024 3:08PM $0.004 $0.525 risen by 13,025%
$114 SPP with Continued Support from Institutional Shareholders 11 Jan 2024 2:24PM $0.004 $0.525 risen by 13,025%
$114 Becoming a substantial holder 10 Jan 2024 4:42PM $0.005 $0.525 risen by 10,400%
$114 Securities Purchase Plan (SPP) Documents Dispatched 10 Jan 2024 9:59AM $0.005 $0.525 risen by 11,566.67%
$114 Change in substantial holding 10 Jan 2024 8:16AM $0.005 $0.525 risen by 11,566.67%
$114 Notification regarding unquoted securities - ATH 8 Jan 2024 4:41PM $0.004 $0.525 risen by 13,025%
$114 Notice Under Section 708A 8 Jan 2024 11:17AM $0.005 $0.525 risen by 11,566.67%
$114 Application for quotation of securities - ATH 8 Jan 2024 11:11AM $0.005 $0.525 risen by 11,566.67%
$114 Alterity Completes Tranche Two of Placement Raising A$3.5M 8 Jan 2024 11:08AM $0.005 $0.525 risen by 11,566.67%
$114 Update - Proposed issue of securities - ATH 5 Jan 2024 11:42AM $0.005 $0.525 risen by 11,566.67%
$114 Update - Proposed issue of securities - ATH 5 Jan 2024 11:31AM $0.005 $0.525 risen by 11,566.67%
$114 Shareholders Approve Tranche Two of Placement and SPP 29 Dec 2023 1:49PM $0.007 $0.525 risen by 7,976.92%
$114 SPP Prospectus 29 Dec 2023 1:33PM $0.007 $0.525 risen by 7,976.92%
$114 Options Prospectus 29 Dec 2023 1:16PM $0.007 $0.525 risen by 7,976.92%
$114 Results of Extraordinary General Meeting 29 Dec 2023 11:40AM $0.007 $0.525 risen by 7,400%
$114 Presentation to Extraordinary General Meeting 29 Dec 2023 8:32AM $0.006 $0.525 risen by 8,650%
$114 Change in substantial holding 22 Dec 2023 8:23AM $0.007 $0.525 risen by 7,400%
$114 Notification regarding unquoted securities - ATH 21 Dec 2023 5:11PM $0.007 $0.525 risen by 7,400%
$114 Alterity Appoints Phillip Hains as Chief Financial Officer 21 Dec 2023 4:13PM $0.007 $0.525 risen by 7,400%
$114 Update - Proposed issue of securities - ATH 18 Dec 2023 9:35AM $0.007 $0.525 risen by 7,400%
$114 Change in substantial holding 14 Dec 2023 8:19AM $0.006 $0.525 risen by 8,650%
$114 Change in substantial holding 12 Dec 2023 8:16AM $0.007 $0.525 risen by 7,400%

226 - 250 of 554 results

Page 10 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.